REDESIGNING EVOLUTION’S PRODUCTS TO TREAT SERIOUS DISEASES


The mission of REVOLUTION Medicines is redesigning evolution’s products to treat serious diseases. The company discovers and develops new drugs by reconfiguring substances that are inherently rich with biological function as a result of natural selection. REVOLUTION Medicines’ innovative product engine is based on the REVEAL™ platform, which uses evolution’s lessons to inform selection of chemical scaffolds, and the REVBLOCKS™ technology, an integrated suite of rapid, agile, and modular synthesis methodologies for using simple chemical “building blocks” to create refined natural product-like structures with optimized pharmacologic and pharmaceutical properties.


Year Invested: 2015
Location: Redwood City, Calif.
Visit: www.revolutionmedicines.com

Recent News

December 20, 2016
REVOLUTION Medicines Raises Additional $25 Million in Series A Financing

December 13, 2016
REVOLUTION Medicines Names Distinguished Cancer Scientists and Drug Hunters to Senior Advisory Roles

June 14, 2016
REVOLUTION Medicines Names Academic Co-Founder, Michael Fischbach, Ph.D., and Senior Advisor, Eric Gordon, Ph.D.

Read More News

Associated Team Members

Mark A. Goldsmith, M.D., Ph.D.
Venture Partner

Alexis Borisy
Partner

Neil Exter
Partner